Smartleaf Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $192K | Sell |
594
-301
| -34% | -$97.2K | 0.02% | 594 |
|
|
2025
Q1 | $240K | Buy |
895
+148
| +20% | +$39.7K | 0.02% | 514 |
|
|
2024
Q4 | $176K | Buy |
747
+306
| +69% | +$72.2K | 0.02% | 587 |
|
|
2024
Q3 | $121K | Buy |
441
+326
| +283% | +$89.6K | 0.01% | 649 |
|
|
2024
Q2 | $28.4K | Buy |
115
+105
| +1,050% | +$25.9K | ﹤0.01% | 901 |
|
|
2024
Q1 | $1.54K | Buy |
+10
| New | +$1.54K | ﹤0.01% | 1518 |
|